Isometric tension was recorded in ring preparations of human superficial temporal arteries contracted by noradrenaline (NA), 5-hydroxytryptamine (5-HT), and ergotamine. In contrast to NA and 5-HT, ergotamine induced long-lasting contractions refractive to additional stimulations and resistant to repeated wash-out. When tested against 5-HT, ergotamine acted as a non-competitive antagonist. When repeating the 5-HT stimulations (4.7 x 10–5 M) the contractile response decreased indicating tachyphylaxis to this agent. As ergotamine revealed both a vasoconstrictive and a 5-HT-blocking activity, the beneficial effect in migraine may be by an interference during both the vasoconstrictory and vasodilatory phases.
AnthonyMLanceJW.The role of serotonin in migraine. In:PearceJ. edModern topics in migraine.London:William Heinemann Medical Books,1975:107–23.
2.
AnthonyMHinterbergerHLanceJW.Plasma serotonin in migraine and stress.Arch Neurol1967;16:544–52.
3.
RydzewskiW.Serotonin (5-HT) in migraine: Levels in whole blood in and between attacks.Headache1976;16:16–19.
4.
SommervilleBW.Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine.Neurology1976;26:41–5.
5.
LanceJWAnthonyMGonskiA.Serotonin, the carotid body, and cranial vessels in migraine.Arch Neurol1967;16:553–8.
6.
GrahamJRWolffHG.Mechanism of migraine headache and action of ergotamine.Arch Neurol Psychiat1938:39:737–63.
7.
SaxenaPRdeVlaam-SchluterGeertrudeM.Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine studies in an experimental model for migraine.Headache1974;13:142–63.
8.
MylecharaneEJSpiraPJMisbachJDuckworthJWLanceJW.Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.Eur J Pharmacol1978;48:1–9.
9.
Müller-ScbweinitzerE.Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.Naunyn Schmiedebergs Arch Pharmacol1976;292:113–18.
10.
Müller-SchweinitzerEWeidmanH.Regional differences in the responsiveness of isolated arteries from cattle, dog, and man.Agents Actions1977;7:383–9.
11.
FozardJR.Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.Eur J Pharmacol1976;36:127–39.
12.
Müller-SchweinitzerEStürmerE.Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.Br J Pharmacol1974;51:441–6.
13.
Müller-SchweinitzerE.Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.Naunyn Schmiedebergs Arch Pharmacol1976;295:41–4.
14.
InnesIR.Identification of the smooth muscle excitatory receptors for ergot alkaloids.Br J Pharmacol1962;19:120–8.
15.
LeionenH.Peripheral blood flow in chronic ergotism.Acta Med Scand1980;207:55–7.
16.
Tfelt-HansenPEickhoffJHOlesenJ.The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: Methodological aspects and time effect curve.Acta Pharmacol Toxicol (Copenh)1980;47:151–6.
FievezMPhilippartFHustinJ.Ergotism. Anatomo-clinical study of a case.Angiology1975;26:491–8.
19.
PaderE.Leriche syndrome in a patient with prolonged and continuous use of ergot derivatives.Vasc Dis1967;4:380–8.
20.
ThompsonWSJrMcClureWWLandowneM.Prolonged vasoconstriction due to ergotamine tartrate: Report of case with recovery, with objective evaluation of vascular findings.Arch Intern Med1950;85:691–8.
21.
BerdeB.Pharmacology of ergot alkaloids in clinical use.Med J Aust (spec suppl),1978;3–13.
22.
EdvinssonLHardeboJE.Demonstration of 5-hydroxytryptamine receptors through inhibition by methergoline in cat pial arteries in vitro.Br J Pharmacol1978;64:281–3.
23.
HardeboJEEdvinssonLOwmanChSvendgaardNAaPotentiation and antagonism of serotonin effects on intracranial and extracranial vessels.Neurology1978;28:64–70.
24.
LamarJ-CHardeboJE.Interaction of a potential antimigraine drug (ORGGC 94) with the vasomotor action of serotonin.Eur J Pharmacol1979;60:263–75.
25.
SvendgaardN AaEdvinssonLOlinTOwmanChSahlinCh.On the pathophysiology of cerebral vasospasm: Transmitter changes in perivascular sympathetic nerves, and increased pial artery sensitivity to norepinephrine and serotonin. In:OwmanChEdvinssonL. edsNeurogenic control of the brain circulation.Oxford:Pergamon Press,1977;143–52.
26.
TodaNFujitaY.Responsiveness of isolated cerebral and peripheral arteries to serotonin, norepinephrine, and transmural electrical stimulation.Circ Res1973;33:98–104.
27.
TodaNHayashiSFuWLHNagasakaY.Serotonin antagonism in isolated canine cerebral arteries.Jpn J Pharmacol1976;26:57–63.
28.
SpiraPJMylecharaneEJLanceJW.The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.Res Clin Stud Headache1976;4:37–75.
29.
MikkelsenELederballePedersenOØstergaardJREllebæk-PetersenS.The effects of ergotamine on human vessels.Arch Int Pharmacodyn Ther,in press1981.
